Matches in Wikidata for { <http://www.wikidata.org/entity/Q34166717> ?p ?o ?g. }
- Q34166717 description "2005 nî lūn-bûn" @default.
- Q34166717 description "2005 թուականի Մարտին հրատարակուած գիտական յօդուած" @default.
- Q34166717 description "2005 թվականի մարտին հրատարակված գիտական հոդված" @default.
- Q34166717 description "2005年の論文" @default.
- Q34166717 description "2005年論文" @default.
- Q34166717 description "2005年論文" @default.
- Q34166717 description "2005年論文" @default.
- Q34166717 description "2005年論文" @default.
- Q34166717 description "2005年論文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005年论文" @default.
- Q34166717 description "2005년 논문" @default.
- Q34166717 description "article científic" @default.
- Q34166717 description "article scientific" @default.
- Q34166717 description "article scientifique (publié 2005)" @default.
- Q34166717 description "articol științific" @default.
- Q34166717 description "articolo scientifico" @default.
- Q34166717 description "artigo científico (publicado na 2005)" @default.
- Q34166717 description "artigo científico (publicado na 2005)" @default.
- Q34166717 description "artigo científico" @default.
- Q34166717 description "artikull shkencor" @default.
- Q34166717 description "artikulong pang-agham" @default.
- Q34166717 description "artykuł naukowy" @default.
- Q34166717 description "artículo científico publicado en 2005" @default.
- Q34166717 description "artículu científicu espublizáu en 2005" @default.
- Q34166717 description "bilimsel makale" @default.
- Q34166717 description "bài báo khoa học" @default.
- Q34166717 description "mokslinis straipsnis" @default.
- Q34166717 description "naučni članak" @default.
- Q34166717 description "scienca artikolo" @default.
- Q34166717 description "scientific article" @default.
- Q34166717 description "teaduslik artikkel" @default.
- Q34166717 description "tieteellinen artikkeli" @default.
- Q34166717 description "tudományos cikk" @default.
- Q34166717 description "vedecký článok" @default.
- Q34166717 description "vetenskaplig artikel" @default.
- Q34166717 description "videnskabelig artikel (udgivet 2005)" @default.
- Q34166717 description "vitenskapelig artikkel" @default.
- Q34166717 description "vitskapeleg artikkel" @default.
- Q34166717 description "vědecký článek" @default.
- Q34166717 description "wetenschappelijk artikel" @default.
- Q34166717 description "wissenschaftlicher Artikel" @default.
- Q34166717 description "επιστημονικό άρθρο" @default.
- Q34166717 description "мақолаи илмӣ" @default.
- Q34166717 description "мақолаи илмӣ" @default.
- Q34166717 description "наукова стаття, опублікована в березні 2005" @default.
- Q34166717 description "научна статия" @default.
- Q34166717 description "научная статья" @default.
- Q34166717 description "научни чланак" @default.
- Q34166717 description "научни чланак" @default.
- Q34166717 description "מאמר מדעי" @default.
- Q34166717 description "سائنسی مضمون" @default.
- Q34166717 description "مقالة علمية" @default.
- Q34166717 description "مقالهٔ علمی" @default.
- Q34166717 description "২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q34166717 description "บทความทางวิทยาศาสตร์" @default.
- Q34166717 description "სამეცნიერო სტატია" @default.
- Q34166717 name "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 name "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 name "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 type Item @default.
- Q34166717 label "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 label "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 label "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 prefLabel "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 prefLabel "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 prefLabel "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 P1433 Q34166717-C8221096-EABE-45E8-A2DF-7B27D7BA98AD @default.
- Q34166717 P1476 Q34166717-902F3125-280D-4986-AA69-B21B9A7F8BF2 @default.
- Q34166717 P2093 Q34166717-DF0EB641-EA9A-47FA-94DD-CA31E1D542A2 @default.
- Q34166717 P2860 Q34166717-501E087C-0B7B-4CE5-9CF5-7182BB4D8ADC @default.
- Q34166717 P2860 Q34166717-58129C13-E5AE-4AF4-B7DF-361FB435A2DC @default.
- Q34166717 P2860 Q34166717-64AD40E6-957E-420F-AE50-ECC7DCED6BAD @default.
- Q34166717 P2860 Q34166717-6E3E9156-C979-405D-8E0F-4F7A722149FC @default.
- Q34166717 P2860 Q34166717-9826175D-53D1-4D53-A418-657E5374A140 @default.
- Q34166717 P304 Q34166717-37098D56-4E49-4DDF-9035-B3F49A9EF4DB @default.
- Q34166717 P31 Q34166717-F0231547-A49C-4526-AF6E-FA644E5D7A8B @default.
- Q34166717 P356 Q34166717-638F34D4-2C5D-4462-B131-7E7D73AD2A27 @default.
- Q34166717 P433 Q34166717-31C159B9-B766-4195-86B5-FB1805DC6816 @default.
- Q34166717 P478 Q34166717-74DA291E-0626-421D-BD6C-C848F3C298CA @default.
- Q34166717 P577 Q34166717-18C9321B-23F5-4EEF-AFE3-F12E52D9F652 @default.
- Q34166717 P5875 Q34166717-383EA54A-311E-4CA8-8CA7-99CE025C9FA4 @default.
- Q34166717 P698 Q34166717-012F256C-9562-4915-BEC0-4D1318FA6B70 @default.
- Q34166717 P921 Q34166717-149C9120-E067-46A9-AC05-2ACDC39E5FBB @default.
- Q34166717 P932 Q34166717-4CBD13AA-E819-4A7F-9977-4544621F0B69 @default.
- Q34166717 P356 SJ.EMBOR.7400353 @default.
- Q34166717 P698 15741969 @default.
- Q34166717 P1433 Q5323356 @default.
- Q34166717 P1476 "Drug safety on trial. Last year's withdrawal of the anti-arthritis drug Vioxx triggered a debate about how to better monitor drug safety even after approval" @default.
- Q34166717 P2093 "Mark Greener" @default.
- Q34166717 P2860 Q28212140 @default.
- Q34166717 P2860 Q34356738 @default.
- Q34166717 P2860 Q35732868 @default.
- Q34166717 P2860 Q36053857 @default.
- Q34166717 P2860 Q45250554 @default.
- Q34166717 P304 "202-204" @default.